[Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004977:Ethambutol; D012293:Rifampin
Sravnitel'naia kharakteristika primeneniia rifadina i etambutola v kompleksnom lechenii bol'nykh fibrozno-kavernoznym tuberkulezom legkikh